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Abstract The quantitative profiling of the organic acid
intermediates of the citric acid cycle (CAC) presents a chal-
lenge due to the lack of commercially available internal
standards for all of the organic acid intermediates. We
developed an analytical method that enables the quantitation
of all the organic acids in the CAC in a single stable isotope
dilution GC/MS analysis with deuterium-labeled analogs used
as internal standards. The unstable a-keto acids are rapidly
reduced with sodium borodeuteride to the corresponding
stable a-deutero-a-hydroxy acids and these, along with their
unlabeled analogs and other CAC organic acid intermediates,
are converted to their tert-butyldimethylsilyl derivatives.
Selected ion monitoring is employed with electron ionization.
We validated this method by treating an untransformed mouse
mammary epithelial cell line with well-known mitochondrial
toxins affecting the electron transport chain and ATP syn-
thase, which resulted in profound perturbations of the con-
centration of CAC intermediates.
Keywords GC/MS  Citric acid cycle  Metabolite
profiling  Mitochondrial toxins
1 Introduction
Mitochondrial functions have been traditionally deter-
mined using in vitro assays, notably quantification of
oxygen consumption, enzyme activities and membrane
potential measurements. The quantitative measurement of
the organic acids associated with the citric acid cycle
(CAC) is of great interest not only due to its intimate
coupling to the electron transport chain and to oxidative
phosphorylation, but also more recently, due to its altered
activity in cancer cells (Mullen et al. 2012) and a renewed
interest in the chemistry of the Warburg effect (Vander
Heiden et al. 2009). The development of novel technolo-
gies that permit the precise quantitative evaluation of
mitochondrial metabolite abundances represents an
important new avenue of research for the monitoring of
mitochondrial functions in physiological and pathological
conditions (Fiehn 2001; Steuer et al. 2003).
The measurement of the CAC intermediates has been a
scientific goal for chemists for a significant period of time.
Early liquid or gas chromatography and mass spectrometry
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studies resulted in difficult quantification of the CAC
intermediates and poorly resolved peaks. Notably, several
techniques resulted in multiple peaks for the unstable keto
acids and did not resolve citric and isocitric acids (Busch
et al. 1952; Dalgliesh et al. 1966; Harmon and Doelle 1969;
Turkelson and Richards 1978; Zaura and Metcoff 1969).
One complicating factor in analyzing the a-keto acids
(oxaloacetic, a-ketoglutaric, and pyruvic acids) is that they
may not be stable under sample extraction conditions and
can spontaneously decarboxylate (Tsai 1967). A solution to
quantitating unstable a-keto acids is to convert them to
their much more stable corresponding a-hydroxy acids
with hydride reducing agents. For example, sodium boro-
deuteride reduction of the branched chain a-keto acid
metabolites of valine, leucine and isoleucine has been
reported to simplify their determination along with their
corresponding a-hydroxy acid metabolites in human serum
using a stable isotope dilution assay (Mamer et al. 1986).
Similarly, urinary pyruvic and acetoacetic acids can be
quantitated by reduction with sodium borodeuteride to
singly labeled lactic and b-hydroxybutyric acids, which can
be measured along with their unlabeled endogenous ana-
logues (Mamer 1988).
In recent years, several techniques have emerged that
could measure CAC intermediates with greater precision,
albeit still with limited coverage. In particular these include
LC–MS/MS techniques developed by Luo et al. 2007 (Luo
et al. 2007) and Koubaa et al. 2013 (Koubaa et al. 2013),
GC/MS methodologies (Dunn and Winder 2011; Kombu
et al. 2011), HPLC-fluorescence methodology (Kubota
et al. 2005), capillary electrophoresis coupled to a mass
spectrometer (CE/MS) (Soga et al. 2003; Wakayama et al.
2010), as well as 1H NMR (Xu et al. 2011). 1H NMR
permits a greater coverage of the CAC intermediates as
well as other metabolites (Xu et al. 2011) and does not
require isotopically labeled internal standards. However, it
is limited by the low micromolar sensitivity and potential
spectral overlap. Furthermore, CAC metabolites such as
a-ketoglutaric, citric, isocitric and cis-aconitic acids are
frequently difficult to detect because of their low abun-
dance (Chatham et al. 2003).
Currently there are varied techniques for measuring
CAC intermediates, each having coverage and/or sensi-
tivity issues. In this paper, we report the development of a
simple, comprehensive, targeted and quantitative technique
that quantifies all organic acid intermediates of the CAC,
addresses the issues of producing one quantifiable peak per
metabolite, provides good chromatographic resolution, and
addresses the stability of the a-keto acids. Our approach is
based on stable isotope dilution selected ion monitoring
(SIM) GC/MS. The a-keto acids, pyruvic, oxaloacetic,
a-ketoglutaric and oxalosuccinic acids are simply extracted
under ice cold conditions then quickly stabilized by
reduction with sodium borodeuteride to form singly deu-





















This reduction converts the relatively unstable a-keto
acids to the much more stable corresponding a-hydroxy-a-
deutero acids for GC/MS analysis. Furthermore, it reduces
the number of isotopically labeled analogs necessary for
quantitative stable isotope dilution experiments, all of
which are commercially available. The resulting acids are
converted to their tert-butyldimethylsilyl (TBDMS) deriv-
atives to take advantage of the intense ½Mþ C4H9þ
fragment ions observed in the spectra of these intermedi-
ates and the improved resolution between citric and iso-
citric acids. We illustrate the use of this method in the
quantitation of the complete CAC organic acid intermedi-
ates in an untransformed mouse mammary epithelial cell
line (NMuMG) under basal conditions or treated with
various mitochondrial electron transport chain inhibitors.
The ability to precisely associate patterns of CAC pertur-
bations to a specific inhibition in the electron transport
chain will facilitate the evaluation of mitochondrial func-
tions in physiology and disease.
2 Experimental methods
2.1 Tissue culture and treatments
Antimycin A (A8674), oligomycin (O4876) and rotenone
(R8875) were purchased from Sigma-Aldrich Canada Ltd.,
Oakville, Ontario, Canada. NMuMG cells were obtained
from the American Type Culture Collection (ATCC). Cells
were grown in an incubator maintained at constant tem-
perature (37 C) and humidity, with 5 % CO2 supply. Cells
were grown in Dulbecco’s Modified Eagle Medium
(DMEM) (Wisent Inc, St. Bruno, Quebec, Canada) sup-
plemented with 10 % fetal bovine serum (Wisent Inc.),
10 lg/mL insulin, 20 mM HEPES pH 7.2 and penicillin/
streptomycin. NMuMG cells were grown to 80 % conflu-
ence (*3,000,000 cells) then trypsinized and counted with
a TC10 automated cell counter (Bio-Rad, Hercules, CA,
USA). For each treatment, 3–5 dishes were used for CAC
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analysis by GC/MS, while 2–3 dishes were used for cell
counting. Three independent cell passages consisting of
three to five replicates were grown in culture. After a
period of 18 h following seeding, the medium was
removed and replaced by complete medium containing
either DMSO (0.4 %, control), antimycin A (10 lM),
rotenone (10 lM) or oligomycin (2.5 lg/106 cells) for 2 h.
2.2 Cell extract sample preparation
The growth medium from each tissue culture plate was
aspirated off and discarded. The plates were carefully
washed three times with 2 mL of ice-cold isotonic saline
solution (9 g/L) and maintained on ice throughout the
procedure. Thoroughly washing cells with normal saline
significantly reduces the amount of phosphate in the sam-
ples. This improves reproducibility from sample to sample
and minimizes the free phosphate damage to the GC col-
umn. A 500 lL volume of 80 % methanol in deionized
distilled water cooled to -80 C, was rapidly pipetted onto
each plate and the cells were scraped loose and transferred
to pre-chilled tubes (this step was repeated twice). Cell
suspensions were quickly vortexed and then subjected to
sonication on ice using the BioRuptor (UCD-200 TM,
Diagenode) for 10 min (30 s ON, 30 s OFF) at the ‘‘high’’
setting. Metabolite suspensions were cleared by centrifu-
gation at 21,000 g at 4 C for 10 min. Each supernatant
was transferred into a fresh pre-chilled tube. A 1 lL vol-
ume of 750 ng/lL D27-myristic acid dissolved in pyridine
was added to each sample as a secondary internal standard.
The pH of the supernatants was adjusted to *11 (on ice
and confirmed using pH paper) by the addition of 5 lL of
2 N NaOH. A 15 lL volume of freshly prepared 10 mg/
mL NaBD4 dissolved in 50 mM NaOH was added to each
sample followed by 20 s of vortexing. The samples were
then moved to and incubated at room temperature for 1 h.
After incubation, samples were acidified to pH 4 by the
addition of 15 lL of 3.5 M HCl. Care was taken to add
acid slowly due to deuterium evolution. Each sample was
spiked with 1 lL of the stable isotope internal standard
mixture (Table 1) post-acidification to avoid base cata-
lyzed back exchange of deuterium with hydrogen. Samples
were frozen and dried in a vacuum centrifuge (Labconco,
Kansas City, MO, USA) at -4 C. Methanol (50 lL) was
added to each sample and evaporated to dryness to remove
boric acid as trimethyl borate. Ensuring that all samples,
solvents and reagents are completely anhydrous greatly
improves reproducibility.
Samples were re-suspended with sonication and vortex
mixing in 30 lL of pyridine and centrifuged ([10,000 g) at
room temperature for 10 min. The supernatants were
transferred to GC/MS autoinjector vials containing 70 lL
N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide
(MTBSTFA) and incubated at 70 C for 1 h. A volume of
1 lL was injected for GC/MS analysis.
2.3 Authentic standards preparation
Authentic unlabeled acids, stable isotope labeled standards,
anhydrous pyridine and MTBSTFA were purchased from
Sigma-Aldrich Canada Ltd. (Oakville, Ontario, Canada),
while NaBD4 and sodium 3,3,3-D3-lactate were purchased
from CDN Isotopes (Pointe-Claire, Quebec, Canada). The
TBDMS derivatives of each organic acid were made and
analyzed individually to acquire authentic mass spectra and
to define retention times and SIM conditions.
To determine the isotopic purity of NaBD4, a solution of
pyruvic, a-ketoglutaric and oxaloacetic acids (*1 ng/lL
20 mM NaOH) was quantitatively reduced in 10 mL of
20 mM NaOH, to which 5 mg of NaBD4 (99.8 at.% D)
was added. The resulting solution was stirred until it was
homogeneous and held at room temperature for 1 h. The
pH of the solution was then lowered to 4 with 3.5 N HCl
added drop-wise (caution, deuterium evolution). This
quantitatively reduced pyruvic, a-ketoglutaric and oxaloa-
cetic acids to a-D1-lactic, a-D1-a-hydroxyglutaric and
a-D1-malic acids, respectively. Volumes of 1, 3 and 5 lL
of this mixture were dried under a stream of nitrogen and
derivatized as described in Sect. 2.2.
2.4 Quantitating internal standard solution preparation
A stock solution of tricarballylic acid and deuterium-
labeled CAC acids was prepared from authentic samples
(Table 1). Carefully weighed quantities were dissolved in
80 mL of 0.05 N NaOH, to which was added 40 mg of
NaBD4. This was held at 50 C for 10 min, acidified with
5 N HCl to pH 4 (caution: deuterium evolution), diluted to
100 mL with distilled water and stored at -30 C. This
quantitatively reduced 3,3,4,4-D4-a-ketoglutaric acid to
2,3,3,4,4-D5-a-hydroxyglutaric acid. Since currently there
are no commercially available isotopologues for cis-
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aconitic acid, tricarballylic acid was used as the quantitating
standard. It is structurally similar to and elutes very close to
cis-aconitic acid. Likewise, labeled and unlabeled oxa-
losuccinic acids were unavailable commercially, but could
be quantitated as D1-isocitric acid against D4-citric acid.
2.5 Preparation of samples for limits of quantitation
calibration
Four stock solutions were prepared containing 1 mM
concentrations of succinic, fumaric, malic, a-hydroxyglu-
taric, cis-aconitic, citric and isocitric acids (solution 1),
a-D1-a-hydroxyglutaric and a-D1-malic acids made from
a-ketoglutaric and oxaloacetic acids by reduction with
NaBD4 (solution 2), lactic acid (solution 3), and a-D1-
lactic acid prepared by reducing pyruvic acid with NaBD4
(solution 4). These four solutions were prepared in tripli-
cate (12 stock solutions). Thirteen serial dilutions were
prepared from each stock solution ranging from 0.002 to
100 nmol per intermediate. A volume of 2 lL of 3,3,3-D3-
lactic acid, 2 lL of the internal standard mixture (Table 1),
and 1 lL of D27-myristic acid were added to each serial
dilution sample. Calibration samples were then dried by
vacuum centrifugation at -4 C. Samples were re-dis-
solved in 30 lL anhydrous pyridine, transferred to auto-
sampler vials containing 70 lL MTBSTFA and incubated
at 70 C for 1 h before being submitted for GC/MS data
acquisition as described in the Sect. 2.6.
2.6 GC/MS analytical conditions
GC/MS analyses were performed with an Agilent 5975C
mass selective detector coupled to a 7890A gas chro-
matograph (Agilent Technologies, Santa Clara, CA, USA)
fitted with a 7693 autosampler and a DB-5MS ? DG
capillary column (30 m plus 10 m Duraguard), diameter
0.25 mm, film thickness 0.25 lm (Agilent J &W, Santa
Clara, CA, USA). The GC temperature program started
with a 1 min hold at 120 C followed by a 10 C/min ramp
to 300 C. Bake-out was at 320 C for 10 min. The injector
and interface to the MS were held at 285 C. The helium
carrier flow rate was held constant at 1.5 mL/min (or a flow
rate such that the TBDMS derivative of to D27-myristic
acid has a retention time of 12.4 min). When operated in
full scan mode, the scan range was 50–700 Da.
The GC/MS was operated in electron ionization mode
(70 eV) and in SIM (monitored ions are listed in Table 2).
In most cases, the heaviest ion in each monitored group
was the ½Mþ C4H9þ fragment, which was used as the
quantitating ion, while the second ion was used for verifi-
cation. It should be noted that in the cases of citric and
isocitric acids, the quantitating ion, m/z 459, is apparently
the Mþ C4H9 tert-C4H9ðCH3Þ2SiOH
 
fragment of the
tetrakis-TBDMS derivative. The hydroxyl hydrogen on the
TBDMS-OH comes from one of the methylene groups in
the citric and isocitric backbones, and the structure of the
resulting ion (m/z 459) may resemble the M-57 ion for
aconitic acid. However in citric D4, TBDMS-OD is lost
(133 Da) and so the ion monitored for citric ‘‘D4’’ contains
only 3 deuteriums, and correction for natural abundance
heavy isotope inclusion in unlabeled citric at m/z 462,
requires the M?3 value. M/z 403 was monitored to confirm
the assignment of citric and isocitric acids; the former has a
much less intense m/z 403 fragment than the latter.
Monitored ion intensities were integrated and exported
into a spreadsheet using MSD Chemstation software and
‘‘RTE’’ integrator (rev E.02.02.1431, Agilent Technolo-
gies, Santa Clara, CA, USA), enabling corrections to
determine the fraction of the M?1 ion intensities of lactic,
malic, a-hydroxyglutaric and isocitric acids due to the
intensities of the deuterium-labeled ions resulting from
NaBD4 reduction of pyruvic, oxaloacetic, a-ketoglutaric
and oxalosuccinic, respectively. Lactic acid requires an
additional commentary, since on our GC/MS we have a
constant lactic background signal. For an absolute measure







3,3,3-D3-lactic 264, 236 6.34 5.50–8.00
D1-lactic 262, 234 6.36 5.50–8.00
Lactic 261, 233 6.36 5.50–8.00
D4-succinic 293, 335 9.26 8.70–10.00
Succinic 289, 331 9.29 8.70–10.00
D2-fumaric 289, 331 9.64 8.70–10.00
Fumaric 287, 329 9.65 8.70–10.00
D3-malic 422, 290 12.67 12.00–13.00
D1-malic 420, 289 12.68 12.00–13.00
Malic 419, 287 12.68 12.00–13.00
D5-a-hydroxyglutaric 438, 249 13.59 13.00–14.00
D1-a-hydroxyglutaric 434, 246 13.61 13.00–14.00
a-hydroxyglutaric 433, 245 13.61 13.00–14.00
Tricarballylic 461, 503 14.98 14.00–16.30
cis-Aconitic 459, 501 15.08 14.00–16.30
D4-citric 462, 434, 406 16.83 16.30–18.00
Citric 459, 431, 403 16.84 16.30–18.00
D1-isocitric
a 460, 432, 404 16.94 16.30–18.00
Isocitric 459, 431, 403 16.94 16.30–18.00
a D1-isocitric is monitored (reduced oxalosuccinic). However, no
authentic internal standards are available for oxalosuccinic acid, nor
have we successfully measured ion intensities nominally for D1-iso-
citric reliably greater than those expected for the M?1 natural
abundance of isocitric acid. We include it here for completeness
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of lactic acid in the cells this background signal should be
subtracted.
2.7 Statistical analyses
Results from DMSO (control) and toxin treated cells were
compared by one-way ANOVA with Dunnett’s multiple
pair-wise comparison tests using significance threshold of
0.05. Calculations were made using GraphPad Prism soft-
ware (GraphPad Software, San Diego, CA, USA).
3 Results and discussion
3.1 Post data acquisition calculations and corrections
After the GC/MS data had been collected and the inte-
grated areas for each metabolite tabulated, corrections were
made to the areas as described previously (Mamer 1988;
Mamer et al. 1986). Briefly, for an endogenous metabolite
‘‘A’’, a NaBD4 reduced mono-deuterated endogenous
metabolite ‘‘A-D1’’ and isotopically labeled internal stan-
dard ‘‘A-Dx’’ (malic, D1-malic and D3-malic for example),
we took into account and corrected for the natural abun-
dance of each detected ion of the isotopic cluster and the
isotopic impurities introduced by the NaBD4 reduction or
the isotopically labeled internal standard. Reducing
authentic unlabeled keto acids and measuring their mass
spectra allowed for the determination of the isotopic
impurity of the NaBD4. The isotopic impurity contribution
from A-D1 to the A integrated intensities was found to be
0.6 % of the A-D1 integrated intensity. It is important to
note that isotopic impurity will be specific to each lot of
NaBD4 used for reduction. The stable isotope standards
were also analyzed for isotopic impurity at 19, 29 and 39
the amount spiked into samples. At these levels, we were
not able to detect any significant unlabeled contribution in
the stable isotope labeled internal standards (A-Dx). Every
new standard purchased will need to be assayed for its
isotopic impurity levels. The measured peak areas for such
an I, I?1 and I?x cluster can be expressed as and are drawn
schematically in Fig. 1:
I ¼ R þ fimpRþ1 þ fimpX0Rþx
Iþ1 ¼ Rþ1 þ fðMþ1ÞR þ fimpX1Rþx
Iþx ¼ Rþx þ fðMþXÞR þ fðDMþXÞRþ1
Parameters in the equations above are defined as follows:
R the correct integrated area for the endogenous metabolite
‘‘A’’, R?1 the corrected value for the reduced a-keto acid
‘‘A-D1’’, R?x the corrected value for the isotopically labeled
internal standard ‘‘A-DX’’, fimp the isotopic impurity intro-
duced from the NaBD4 reduction of the a-keto acid, fimpX0
the isotopic impurity introduced by the addition of the iso-
topically labeled standard to the I peak area, fimX1 the isotopic
impurity introduced by the labeled standard to the I?1 peak
area, f(M?1) the fractional value of natural isotopic abundance
of the first isotopic of A, f(M?X) the fractional value of natural
isotopic abundance of the Xth isotope of A, f(DM?X) the
fractional value of the natural isotopic abundance of the Xth
isotope of the A-D1 reduced a-keto acid.
The fractional isotope values can be calculated or
measured experimentally using authentic samples. Thus,
there are nominally three equations and three unknowns,
but since the contribution of isotopic impurity from the
internal standard is negligible in the present example, one
can solve for R and R?1 using simple substitution (two
equations with two unknowns). Isotopic ratios were mea-
sured experimentally and calculated using an online cal-
culator (http://yanjunhua.tripod.com/pattern1.htm), or the
program ‘‘Isoform’’ (v1.02, NIST 1997). The experi-
mentally measured isotopic ratios were within 2 % of those
calculated. The corrections used for the data presented in
this manuscript are as follows:
Lactic, D1-lactic, D3-lactic
R261 ¼ ð1:0014  I261Þ  ð0:0060  I262Þ
R262 ¼ ð1:0014  I262  ð0:2285  I261Þ
R264 ¼ I264  ð0:0146  R261Þ  ð0:0960  R262Þ
Malic, D1-malic, D3-malic


















Fig. 1 A schematic diagram illustrating the natural abundance
isotopic and isotopic impurity contributions expected for peak areas
I, I?1 and I?x. The values for R (black), R?1 (red) and R?X (blue)
were each set to 100 while the values for fimp, fimpX0, fimpX1, f(M?1) and
fD(M?1) were arbitrarily set to 10, 5, 10, 40, 20 and 15 % respectively.
The multiplication factors are measured experimentally for isotopic
impurities and calculated for natural isotopic abundances
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R420 ¼ ð1:0021  I420Þ  ð0:3487  I419Þ
R422 ¼ I422  ð0:0408  R419Þ  ð0:1704  R420Þ
a-Hydroxyglutaric, D1-a-hydroxyglutaric, D5-a-hydroxy-
glutaric
R433 ¼ ð1:0022  I433Þ  ð0:0060  I434Þ
R434 ¼ ð1:0022  I434Þ  ð0:3677  I433Þ
R438 ¼ I438  ð0:0018  R433Þ  ð0:0104  R434Þ
Isocitric, D1-isocitric (D4-citric is used as the internal
standard as it is well resolved from isocitric)
R459 ¼ ð1:0023  I459Þ  ð0:0060  I460Þ
R460 ¼ ð1:0023  I460Þ  ð0:3829  I459Þ
After these corrections were made, the amount of each
metabolite could be calculated from the ratio of the cor-
rected peak areas multiplied by the stable isotopologue
concentration (e.g. [Lactic] = R261/R264*[D3-lactic]). The
results from the cell extractions were expressed as nano-
moles per million cells.
We selected deuterium labeled internal standards over
those with 13C labeling as the former are more widely
available and less expensive than the latter. In our expe-
rience, the sites of deuterium labeling in the chosen internal
standards are refractory to exchange at room temperature
and in weakly acidic solutions (experimentally confirmed,
data not shown).
3.2 a-Keto acid stability
A small amount of each a-ketoglutaric, oxaloacetic and
pyruvic acid was directly added to 30 lL of pyridine,
derivatized with MTBSTFA and analyzed as described in
the experimental section. Pyruvic acid gave the expected
bis-TBDMS derivative along with a very small secondary
peak, the nature of which we could not identify. a-Keto-
glutaric acid gave three peaks corresponding to bis-, tris-
and tetrakis-TBDMS derivatives. A small amount of
succinic acid was also detected (*2 % by integral com-
parison). Interestingly, the oxaloacetic acid did not appear
to be stable under these conditions. A very small peak of
the tris-TBDMS derivative of oxaloacetic acid was detec-
ted in addition to a very large pyruvic acid peak. The same
approach was taken again, except samples were methoxi-
mated in pyridine before derivatization and GC/MS data
collected as described in the Supplementary Materials.
Methoximated a-ketoglutaric formed the expected single
peak with a slightly lower level of succinic acid (0.5 % by
integral comparison). The oxaloacetic methoxime also
formed one peak, along with a pyruvic peak (*15 % by
integral comparison). For a quick test of stability, small
amounts of pyruvic, oxaloacetic and a-ketoglutaric acids
were dissolved individually in 20 lL of basic, acidic and
neutral 80 % methanol mimicking the potential range of
extraction conditions. Triplicate samples were held at room
temperature for 2 h. We found that a-ketoglutaric acid
decarboxylated to a greater extent under basic compared
with acidic conditions, while pyruvic acid appears to
degrade to a greater extent under acidic conditions com-
pared to neutral and basic conditions. Oxaloacetic acid
appears equally unstable under all conditions tested (Sup-
plemental Fig. S1). The decarboxylation of oxaloacetic
acid to pyruvic has been noted by Kubota et al. (2005) and
shown by Tsai (1967) to have a first order reaction rate
constant of 7.23 9 10-3 min-1 at 30 C in water.
Furthermore, we measured how quickly NaBD4 reduc-
tion of the a-keto acids took place compared to their
decarboxylation. The reaction kinetics (described in Sup-
plemental Materials) were assumed to be pseudo-first order
in a-keto acid due to the excess amount of NaBD4. The rate
of reduction for the a-keto acids ranged from 0.3 to
1.3 min-1 at room temperature over four independent
replicate reactions (see Supplemental Fig. S2). The rate of
oxaloacetic acid reduction may be faster but we were
unable to collect time point aliquots faster than every
20–30 s (see Supplemental Fig. S2 B). These rates should
be considered approximate since they are heavily depen-
dent upon the amount of NaBD4 compared to the a-keto
acid amount. Under our reaction conditions, NaBD4 is
added in five fold molar excess to ensure pseudo-first
order rate conditions. Under the conditions of these anal-
yses, the rate of reduction is over forty to two hundred
times faster than the rate of decarboxylation reported by
Tsai (1967).
In order to ensure that the extraction conditions did not
cause excessive decarboxylation, we tested three different
extraction conditions in triplicate, namely 80 % cold
methanol, basic 80 % cold methanol (pH 11) and basic
80 % cold methanol to which 15 lL of 5 mg/mL of NaBD4
were added before the cells were lysed by sonication. The
levels of each quantified CAC acid did not change signif-
icantly with different conditions, ensuring that the simple
80 % methanol extraction does not cause significant
decarboxylation so long as samples are kept as cold as
possible up to the point of reduction (see Supplemental
Fig. S3). Additionally, we do not perform any additional
solvent based organic acid extractions to further isolate
CAC organic acids in our sample preparation since the
efficiency of the CAC organic acid extraction depends on
the amount of the acid present in the crude extract
(Szmigielska et al. 1995). Based on the evidence presented,
we are confident that our methodology minimizes the loss
of a-keto acids to decarboxylation and the levels of
quantified CAC organic acid intermediates accurately
reflect those of the cell or tissue.
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3.3 Limits of quantitation
The limits of quantitation (LOQ) were measured for all of
the CAC organic acids. A summary of these limits is found
in Table 3. The calibration curves measured in triplicate
from freshly prepared solutions can be found in Supple-
mentary Fig. S4. The upper and lower limits of quantitation
are dynamic and depend on the physical status of the mass
spectrometer. Some factors that can contribute to loss of
sensitivity and dynamic range are the cleanliness of the ion
source, the quadrupoles, lenses and age of the detector.
Because this methodology uses stable isotope dilution
techniques, the isotope corrected integral values for the
internal standards should remain relatively constant from
sample to sample.
In the case of the upper limit, if the corrected integral of
the stable isotope internal standard associated with the
organic acid of interest is much larger than that of the other
samples (or samples containing only the internal stan-
dards), then the upper limit for that particular metabolite
has been exceeded and the sample should be diluted and
re-run. In this case the metabolite peak is truncated since
the electron multiplier output is no longer proportional to
ion current input thus compromising the isotopic ratios.
For the lower limit of non-reduced metabolites, the
chromatogram must be examined to determine if the low-
level peak signal is sufficiently above the noise level (S/N
10:1). Under low resolution GC/MS conditions, the a-
hydroxy acids produced by the reduction of the four a-keto
acids with sodium borodeuteride will co-elute with the
corresponding four endogenous unlabeled a-hydroxy acids,
and their [M-57]? fragments will have the same nominal
masses as the [M-56]? first isotope peaks of the unlabeled
a-hydroxy acids. In all four cases, the former may be less
intense than the latter, and the limits of quantitation for the
a-keto acids will then be related to the standard deviations
measured for the intensities of the [M-56]? ions in tech-
nical replicates of the unlabeled a-hydroxy acids (Table 3).
We assume that the lower limit of quantitation is reached
when the analyte signal is less than 10 times the noise,
where the ‘noise’ is defined as the standard deviation for
the intensity of the [M-56]? in each of the unlabeled a-
hydroxy acids. The standard deviations measured are listed
in Table 3. We report the LOQ for the CAC acids as the
points where the calibrating plots depart significantly from
linearity at the high and low ends.
3.4 Mitochondrial toxin perturbation of the citric acid
cycle
Figure 2 shows the selected ion chromatograms for the
authentic standards and extracts of cells exposed to DMSO
(control), antimycin A, rotenone, and oligomycin. It is
important to appreciate that all targeted metabolites are
well resolved including citric and isocitric acids. The
reduced mono-deuterated species and internal standards
co-elute with their corresponding non-deuterated metabo-
lites (Fig. 2).
Figure 3 shows box and scatter plots of CAC interme-
diates measured for five replicates. All of the CAC organic
acid intermediates were successfully quantified except for
oxalosuccinic acid (which would be reduced to D1-isocitric
acid). We have not detected oxalosuccinic acid as D1-iso-
citric acid in various cell lines and tissue extracts (data not
shown). It is likely to be below the limits of detection,
unstable during the cell extraction or precipitated along
with the enzyme, isocitric dehydrogenase, to which it is
reported to be tightly bound (Siebert et al. 1957). Oxa-
losuccinic acid has, however, been measured in hydroge-
nobacter thermophylus TK-6 (Aoshima and Igarashi 2006).
Table 3 Upper and lower
limits of quantitation for CAC
organic acid intermediates
These limits of detection reflect
the current state of our GC/MS
system and can change over
time—see text
a Uncorrected for background
lactic









Lactic 80 0.5a 0.99/0.99 0.006
D1-lactic (pyruvic) 25 0.01 0.96/0.96
Succinic 100 0.01 0.99/0.99
Fumaric 75 0.05 0.99/0.99
Malic 75 0.05 0.99/0.99 0.004
D1-malic (oxaloacetic) 60 0.01 0.99/0.99




cis-Aconitic 75 0.01 0.99/0.99
Citric 100 0.01 0.99/0.99
Isocitric 100 0.01 0.99/0.99 0.002
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As a first proof of principle, we wanted to quantify the
lactic acid concentration of control cells and cells exposed
to mitochondrial toxins. These mitochondrial drugs are
expected to halt ATP production, and the cells compensate
by increasing flux through the glycolytic pathway, pyruvate
to lactate, as observed in Fig. 3. A schematic of the CAC
along with bar graphs of mitotoxin response normalized to
DMSO control metabolite levels are shown in Fig. 4 for
three independent cell passages.
In order to perturb the concentration of CAC interme-
diates, we first treated cells with antimycin A, an inhibitor
of complex III. It is expected that a blockade of the electron
transport chain at complex III will result in an accumula-
tion of upstream metabolites, notably FADH2, which in
Fig. 2 The selected ion current chromatograms for a authentic stan-
dards, b DMSO treated cells, c antimycin A treated cells, d rotenone
treated cells, and e oligomycin treated cells. Selected ion monitoring
data were collected for analytical samples using ions listed in Table 2.
Numbers above authentic standard peaks represent unlabeled and
reduced deuterium-labeled 1 lactic and D1-lactic, 2 succinic, 3 fumaric,
4 D27-myristic, 5 malic and D1-malic, 6 a-hydroxyglutaric and a-D1-



















































































































































































Fig. 3 Typical analysis of citric
acid cycle organic acid
intermediates quantified by
selected ion monitoring GC/MS
for a single cell passage and five
replicates for each treatment.
The distributions are displayed
as box plots of DMSO (black),
antimycin A (red), rotenone
(green), and oligomycin (blue)
exposed cells normalized per
million cells. Note that the plot
for succinic acid contains a
break in the vertical axis due to
its large range in concentration.
Treated groups were compared
to DMSO using one-way
ANOVA with Dunnett’s
multiple comparisons test;
*P value \ 0.05,
**P value \ 0.01,
***P value \ 0.001
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turn will lead to an accumulation of succinic acid by
reversal of the succinate dehydrogenase reaction. Indeed,
cells treated with antimycin A displayed large increases in
succinic compared with controls (Figs. 3, 4). Treatment of
cells with antimycin A is also expected to result in the
accumulation of NADH, which is upstream of complex III
in the electron transport chain. Elevated NADH levels will
cause the inhibition of three CAC enzymes, citrate syn-
thase, isocitrate dehydrogenase and a-ketoglutarate dehy-
drogenase, in addition to halting the pyruvate
dehydrogenase complex, which provides acetyl coenzyme
A for the citrate synthase reaction. In agreement with this,
cells treated with antimycin A had reduced concentrations
of citric, cis-aconitic and a-ketoglutaric acids compared to
control cells (Figs. 3, 4). A complementary explanation for
these results is that an increased redox state can lead to the
reversal of the citric acid cycle, whereby amino acids are
converted to a-ketoglutaric acid, which in turn, is con-
verted to isocitric acid and from this point the cycle is
running in a counter-clockwise direction (Metallo et al.
2012; Mullen et al. 2012). In support of this point, cells
treated with antimycin A exhibited an accumulation of
a-hydroxyglutaric acid, a metabolite that can be generated














































































































Fig. 4 A schematic of the citric acid cycle. The small bar graphs
associated with each organic acid represent the level of each
metabolite detected normalized against the control DMSO treatment.
The error bars represent the standard error of the mean (SEM) for
three separate cell passages. The cell treatments are indicated as black
DMSO, red antimycin A, green rotenone, and blue oligomycin.
A quantitative visualization of the measured data is displayed in
Fig. 3. Acetyl- and succinyl-CoAs (indicated in red) are not measured
by the technique described here. As discussed in the text, oxalosucci-
nic acid (indicated in purple), which is reduced by sodium borodeu-
teride, was not detected as D1-isocitric acid, but is included here for
completeness
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(Figs. 3, 4) (Wise et al. 2011). The reduced levels of CAC
intermediates upstream of a-ketoglutaric acid during
reverse activity would be explained by the fact that citric
acid is diverted from the cycle for lipid biosynthesis (Filipp
et al. 2012; Metallo et al. 2012; Mullen et al. 2012).
Finally, it is important to point out that during the diversion
of CAC intermediates for biosynthesis reactions, pyruvate
carboxylase can help replenish those intermediates by
converting pyruvic to oxaloacetic acid. In agreement with
this point, antimycin A led to a similar change in the
profiles of pyruvic and oxaloacetic acids (Figs. 3, 4).
The second treatment to perturb the CAC intermediates
was to treat cells with rotenone, a complex I inhibitor that
will cause accumulation of NADH. As mentioned before,
NADH globally limits CAC activity by inhibiting three of
its enzymes as well as the pyruvate dehydrogenase com-
plex, which provides the starting material for the cycle,
acetyl coenzyme A. In support of the blockade of the initial
steps of the citric acid cycle, cells treated with rotenone
displayed reduced concentrations of citric, cis-aconitic and
isocitric acids (Figs. 3, 4). The levels of a-ketoglutaric and
a-hydroxyglutaric acids were elevated in cells treated with
rotenone compared with controls, indicating reverse CAC
activity in the presence of the mitochondrial toxin (Figs. 3,
4). Finally, the levels of malic and oxaloacetic acids were
higher in cells treated with rotenone than controls, likely
due to a combination of the reversal of the malate dehy-
drogenase reaction through NADH accumulation as well as
pyruvate carboxylase activity.
Lastly, we determined the impact of the ATP synthase
inhibitor, oligomycin, on the concentration of the inter-
mediates of the citric acid cycle. Oligomycin is expected to
slow down the electron transport chain and the citric acid
cycle. Even though oligomycin is expected to affect the
electron transport chain globally, we observed that the
CAC metabolite profile in the presence of this mitotoxin
was most similar to that of rotenone (Figs. 3, 4), perhaps
highlighting the sensitivity of the CAC to perturbation in
NADH levels.
In summary, cells treated with the 3 mitochondrial drugs
displayed an elevated glycolytic flux as illustrated by a
significant rise in intracellular lactic acid concentration
compared with DMSO controls (Fig. 3). Xu et al. (2011)
report similar results for changes in lactic, malic, fumaric,
and succinic acid levels in myotube cells treated with
rotenone or antimycin A, but no significant changes in
pyruvic, oxaloacetic or citric acids.
4 Conclusions
We describe a simple quantitative method for profiling all
of the organic acids of the citric acid cycle, even for those
that are unstable or lacking commercially available stable
isotope analogues. Crude cell extracts were reduced with
sodium borodeuteride, stable isotopically labeled ana-
logues were added, and resulting samples were derivatized
with MTBSTFA followed by SIM GC/MS. The resulting
integrated peak areas were then corrected and compared to
the peak areas of internal isotopically labeled standards.
Through the use of three mitochondrial toxins, we dem-
onstrated that this technique can be used to reveal specific
signatures of CAC intermediates during inhibition of the
electron transport chain complexes (Fig. 4).
Many laboratories are interested in defining mitochon-
drial functions in physiological and pathological conditions
in a more quantitative manner. Given that the CAC is
amphibolic in nature such that it plays a central role in
catabolic and anabolic functions, the quantitative profiling
of these intermediates is a central tool in basic or applied
metabolic research.
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